BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 25100240)

  • 1. Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. aureus disease.
    Conlon BP
    Bioessays; 2014 Oct; 36(10):991-6. PubMed ID: 25100240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Toxin-Antitoxin MazEF Drives Staphylococcus aureus Biofilm Formation, Antibiotic Tolerance, and Chronic Infection.
    Ma D; Mandell JB; Donegan NP; Cheung AL; Ma W; Rothenberger S; Shanks RMQ; Richardson AR; Urish KL
    mBio; 2019 Nov; 10(6):. PubMed ID: 31772059
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibiotic tolerance in biofilm persister cells of Staphylococcus aureus and expression of toxin-antitoxin system genes.
    Karimaei S; Kazem Aghamir SM; Foroushani AR; Pourmand MR
    Microb Pathog; 2021 Oct; 159():105126. PubMed ID: 34384900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pursuit of Staphylococcus aureus continues: a role of persister cells.
    Chang J; Lee RE; Lee W
    Arch Pharm Res; 2020 Jun; 43(6):630-638. PubMed ID: 32627141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persister formation in Staphylococcus aureus is associated with ATP depletion.
    Conlon BP; Rowe SE; Gandt AB; Nuxoll AS; Donegan NP; Zalis EA; Clair G; Adkins JN; Cheung AL; Lewis K
    Nat Microbiol; 2016 Apr; 1():16051. PubMed ID: 27572649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recalcitrant Staphylococcus aureus Infections: Obstacles and Solutions.
    Rowe SE; Beam JE; Conlon BP
    Infect Immun; 2021 Mar; 89(4):. PubMed ID: 33526569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of Staphylococcus aureus biofilms.
    Bhattacharya M; Wozniak DJ; Stoodley P; Hall-Stoodley L
    Expert Rev Anti Infect Ther; 2015; 13(12):1499-516. PubMed ID: 26646248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of Staphylococcus aureus persister cells with the host when in a persister state and following awakening.
    Mina EG; Marques CN
    Sci Rep; 2016 Aug; 6():31342. PubMed ID: 27506163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug tolerance of biofilms and persister cells.
    Lewis K
    Curr Top Microbiol Immunol; 2008; 322():107-31. PubMed ID: 18453274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. msaABCR operon is involved in persister cell formation in Staphylococcus aureus.
    Sahukhal GS; Pandey S; Elasri MO
    BMC Microbiol; 2017 Nov; 17(1):218. PubMed ID: 29166860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic tolerance and the alternative lifestyles of
    Bui LM; Conlon BP; Kidd SP
    Essays Biochem; 2017 Feb; 61(1):71-79. PubMed ID: 28258231
    [No Abstract]   [Full Text] [Related]  

  • 12. High level of persister frequency in clinical staphylococcal isolates.
    Manandhar S; Singh A; Varma A; Pandey S; Shrivastava N
    BMC Microbiol; 2022 Apr; 22(1):109. PubMed ID: 35448965
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Theis TJ; Daubert TA; Kluthe KE; Brodd KL; Nuxoll AS
    Front Cell Infect Microbiol; 2023; 13():1178526. PubMed ID: 37228667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High persister cell formation by clinical
    Liu L; Wang Y; Bojer MS; Andersen PS; Ingmer H
    Microbiology (Reading); 2020 Jul; 166(7):654-658. PubMed ID: 32427093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular reprogramming and phenotype switching in
    Huemer M; Mairpady Shambat S; Bergada-Pijuan J; Söderholm S; Boumasmoud M; Vulin C; Gómez-Mejia A; Antelo Varela M; Tripathi V; Götschi S; Marques Maggio E; Hasse B; Brugger SD; Bumann D; Schuepbach RA; Zinkernagel AS
    Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33574060
    [No Abstract]   [Full Text] [Related]  

  • 16. Macrophage-Produced Peroxynitrite Induces Antibiotic Tolerance and Supersedes Intrinsic Mechanisms of Persister Formation.
    Beam JE; Wagner NJ; Shook JC; Bahnson ESM; Fowler VG; Rowe SE; Conlon BP
    Infect Immun; 2021 Sep; 89(10):e0028621. PubMed ID: 34097475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical and experimental evidence for eliminating persister bacteria by manipulating killing timing.
    Cogan NG; Rath H; Kommerein N; Stumpp SN; Stiesch M
    FEMS Microbiol Lett; 2016 Dec; 363(23):. PubMed ID: 27915255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Antibiotic Failure During
    Gimza BD; Cassat JE
    Front Immunol; 2021; 12():638085. PubMed ID: 33643322
    [No Abstract]   [Full Text] [Related]  

  • 19. pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms.
    Lebeaux D; Chauhan A; Létoffé S; Fischer F; de Reuse H; Beloin C; Ghigo JM
    J Infect Dis; 2014 Nov; 210(9):1357-66. PubMed ID: 24837402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of clpP and clpC deletion on persister cell number in Staphylococcus aureus.
    Springer MT; Singh VK; Cheung AL; Donegan NP; Chamberlain NR
    J Med Microbiol; 2016 Aug; 65(8):848-857. PubMed ID: 27375177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.